Viability and DNA damage responses of TPPII-deficient Myc- and Ras-transformed fibroblasts
- Department of Radiation Oncology, University Hospital Freiburg, Freiburg (Germany)
- Institute of Molecular Medicine and Cell Research, Center for Biochemistry and Molecular Cell Research, Albert-Ludwig University, Freiburg (Germany)
- Helmholtz Zentrum Muenchen, German Research Center for Environmental Health, Institute of Clinical Molecular Biology and Tumor Genetics, Muenchen (Germany)
Tripeptidyl peptidase II (TPPII) is a giant cytosolic protease. Previous protease inhibitor, overexpression and siRNA studies suggested that TPPII is important for viability and proliferation of tumor cells, and for their ionizing radiation-induced DNA damage response. The possibility that TPPII could be targeted for tumor therapy prompted us to study its role in transformed cells following genetic TPPII deletion. We generated cell lines from primary fibroblasts having conditional (floxed) TPPII alleles, transformed them with both the c-myc and H-ras oncogenes, and deleted TPPII using retroviral self-deleting Cre recombinase. Clonally derived TPPIIflox/flox and TPPII-/- transformed fibroblasts showed no influences of TPPII expression on basal cell survival and proliferation, nor on radiation-induced p53 activation, p21 induction, cell cycle arrest, apoptosis, or clonogenic cell death. Thus, our results do not support a generally important role of TPPII for viability and proliferation of transformed cells or their p53-mediated DNA damage response.
- OSTI ID:
- 22199779
- Journal Information:
- Biochemical and Biophysical Research Communications, Vol. 386, Issue 4; Other Information: Copyright (c) 2009 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.; Country of input: International Atomic Energy Agency (IAEA); ISSN 0006-291X
- Country of Publication:
- United States
- Language:
- English
Similar Records
Neoplastic transformation and tumorigenesis by the human protooncogene MYC
MAML1 regulates cell viability via the NF-{kappa}B pathway in cervical cancer cell lines